Talent equity

RSA Talent Talks debut Podcast

We’re seeing some of the most exciting new therapeutics emerge from the Cell & Gene Therapy Sector, it’s happening quickly and delivering meaningful results...

What next for EU and UK biotech boards?

In light of the UK’s decision to leave the EU, it’s worth revisiting our recent Talent Equity® report on what makes successful biotech boards. The question...